Reckitt shares jump after US jury backs Mead Johnson in formula case
Reckitt shares rose 5% after a U.S. jury backed its unit Mead Johnson in a baby formula lawsuit alleging Enfamil preterm formula caused serious bowel disease.
Reckitt's shares LSE:RKT rose 5% on Tuesday after a U.S. jury sided with its unit, Mead Johnson, in a case alleging that its Enfamil preterm baby formula caused a serious bowel disease, handing the company a boost in the litigation that has weighed on its stock.The unanimous jury verdict in the U.S…